128 related articles for article (PubMed ID: 11355587)
1. [A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer versus conventionally fractionated 60 Gy: results of a randomized equivalence study].
Zagamé L; Noël G; Mazeron JJ
Cancer Radiother; 2001 Apr; 5(2):199. PubMed ID: 11355587
[No Abstract] [Full Text] [Related]
2. Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria.
Graham MV; Byhardt RW; Sause WT; Curran WJ; Fuller D; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA
Radiology; 2000 Jun; 215 Suppl():1347-62. PubMed ID: 11037551
[No Abstract] [Full Text] [Related]
3. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
4. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
5. Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria.
Komaki R; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Weisenburger TH; Kaiser LR; Leibel SA; Choi NC
Radiology; 2000 Jun; 215 Suppl():1319-30. PubMed ID: 11037549
[No Abstract] [Full Text] [Related]
6. Results of the Dutch National study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer.
Kramer GW; Wanders SL; Noordijk EM; Vonk EJ; van Houwelingen HC; van den Hout WB; Geskus RB; Scholten M; Leer JW
J Clin Oncol; 2005 May; 23(13):2962-70. PubMed ID: 15860852
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer.
Neville A
Clin Evid; 2002 Jun; (7):1369-83. PubMed ID: 12230752
[No Abstract] [Full Text] [Related]
8. Palliative treatment of advanced non small cell lung cancer with weekly fraction radiotherapy.
Bhatt ML; Mohani BK; Kumar L; Chawla S; Sharma DN; Rath GK
Indian J Cancer; 2000 Dec; 37(4):148-52. PubMed ID: 12018566
[TBL] [Abstract][Full Text] [Related]
9. [Radiation treatment of lung cancer].
Hayakawa K
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1211-4. PubMed ID: 17847583
[No Abstract] [Full Text] [Related]
10. Palliative percutaneous radiotherapy in non-small-cell lung cancer.
Budach W; Belka C
Lung Cancer; 2004 Aug; 45 Suppl 2():S239-45. PubMed ID: 15552805
[TBL] [Abstract][Full Text] [Related]
11. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
12. A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 Gy: results of a randomized equivalence study: regarding Nestle et al. IJROBP 2000; 48:95-103.
Byhardt R; Scott C
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):837. PubMed ID: 11417531
[No Abstract] [Full Text] [Related]
13. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
Koukourakis M
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
[No Abstract] [Full Text] [Related]
14. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
Unlu I; Diniz G; Komurcuoglu B; Gayaf M; Gokce T; Karadogan I; Akcay C
Saudi Med J; 2006 Jun; 27(6):849-53. PubMed ID: 16758049
[TBL] [Abstract][Full Text] [Related]
15. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
[TBL] [Abstract][Full Text] [Related]
16. A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60 GY: results of a randomized equivalence study.
Nestle U; Nieder C; Walter K; Abel U; Ukena D; Sybrecht GW; Schnabel K
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):95-103. PubMed ID: 10924977
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation?
Chen M; Hayman JA; Ten Haken RK; Tatro D; Fernando S; Kong FM
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):120-6. PubMed ID: 16198503
[TBL] [Abstract][Full Text] [Related]
18. Localized small-cell lung cancer: which type of thoracic radiotherapy and which time schedule.
Stuschke M; Pöttgen C
Lung Cancer; 2004 Aug; 45 Suppl 2():S133-7. PubMed ID: 15552793
[TBL] [Abstract][Full Text] [Related]
19. Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions.
Hatton MQ; Martin JE
Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):356-64. PubMed ID: 20399629
[TBL] [Abstract][Full Text] [Related]
20. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
